Autonomix Medical, Inc. has been granted a new U.S. patent—U.S. Patent No. 12,295,646—for its innovative "Smart Torquer and Methods for Using the Same," a critical advancement in the company's mission to enhance precision and control in minimally invasive, nerve-targeted procedures. This smart torquer device is engineered to improve the manipulation of elongated intravascular instruments while integrating electronic systems for seamless mechanical control and data communication. The patent significantly strengthens Autonomix’s IP portfolio, which now includes over 80 issued patents, and supports its strategic focus on reshaping interventional care across high-need specialties such as cardiology, neurosurgery, and interventional radiology.
The smart torquer comprises a multi-functional mechanism that attaches securely to intravascular tools, enabling clinicians to deliver targeted torque while simultaneously transmitting signals and data. This integration is particularly beneficial in procedures where precision navigation and real-time feedback are essential, such as in nerve mapping, ablation, and complex vascular access. The device’s built-in communication module and electrical connection interface support interoperability with broader systems, positioning it as a key enabler for intelligent, connected surgical workflows. By combining tactile control with digital connectivity, Autonomix is addressing critical limitations in existing intravascular navigation tools and improving procedural accuracy.
This patent also complements Autonomix’s broader nerve-targeted therapy platform, which features a proprietary catheter-based microchip array capable of sensing and distinguishing neural signals with high sensitivity. This precision mapping is paired with radiofrequency (RF) ablation to treat targeted nerves, offering a “sense, treat, and verify” approach that has the potential to transform how chronic pain, cardiovascular conditions, and neurological disorders are treated. With growing interest in minimally invasive, targeted interventions, the newly patented smart torquer technology is expected to play a pivotal role in expanding Autonomix’s reach into multi-billion-dollar therapeutic markets and in advancing the next generation of intelligent interventional tools.
MedTech Spectrum's Summary
Patent Strengthens Innovation Edge: Autonomix Medical’s newly granted U.S. patent for its Smart Torquer device reinforces its intellectual property portfolio and enhances its leadership in precision nerve-targeted, minimally invasive treatments.
Improved Control and Integration: The Smart Torquer combines mechanical manipulation with electronic signal and data communication, offering clinicians greater control and real-time feedback during complex intravascular procedures.
Foundation for Future Growth: This patent supports the expansion of Autonomix’s platform into high-impact areas like cardiology, neurosurgery, and pain management, advancing its mission to reshape outcomes through connected, nerve-focused interventions.
